Clinical Challenges: Treatment of Psoriatic Arthritis
MedPage Today,
Clinical Challenges > Psoriatic Arthritis Currently available options include new targeted biologics and oral small molecules…
Clinical Challenges > Psoriatic Arthritis Currently available options include new targeted biologics and oral small molecules…
The long-term efficacy and safety of secukinumab (Cosentyx) in psoriatic arthritis has now been confirmed, with the publication…
Action Points Note that this randomized study found that the Il-17a inhibitor secukinumab was efficacious in improving symptoms…
Action Points Secukinumab (Cosentyx), an anti-interleukin 17A (ILS-17A) antibody, improved signs and symptoms of ankylosing…